Different particulate systems—bypass the biological barriers?

References

• Abbott NJ. (2002). Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat, 200: 629–638.
   PubMed Web of Science ®Google Scholar
• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. (2006). Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev, 58(15): 1688–1713.
   PubMed Web of Science ®Google Scholar
• Afergan E, Epstein H, Dahan R, Koroukhov N, Rohekar K, Danenberg HD, Golomb G. (2008). Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J Control Release, 132: 84–90. 10.1016/j.jconrel.2008.08.017.
   PubMed Web of Science ®Google Scholar
• Ajit PR, Sunil AA, Sangamesh AP, Nadagouda NM, Padmakar VK and Tejraj MA. (2006). Semi-interpenetrating polymer network microspheres of gelatin and sodium carboxymethyl cellulose for controlled release of ketorolac tromethamine. Carbohydr Polym, 65(3): 243–252.
   Web of Science ®Google Scholar
• Alonso MJ, Sánchez A. (2003). The potential of chitosan in ocular drug delivery. J Pharm Pharmacol, 55: 1451–1463. 10.1211/0022357022476.
   PubMed Web of Science ®Google Scholar
• Ambruosi A, Gelperina S, Khalansky A, Tanski S, Theisen A, Kreuter J. (2006). Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. J Microencapsul, 23: 582–592. 10.1080/02652040600788080.
   PubMed Web of Science ®Google Scholar
• Amiji MM. (2007). Nanotechnology for Cancer Therapy. CRC Press, New York.
   Google Scholar
• Attama AA, Reichl S, Müller-Goymann CC. (2008). Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm, 355: 307–313. 10.1016/j.ijpharm.2007.12.007.
   PubMed Web of Science ®Google Scholar
• Basu SC, Basu M. (2002). Liposome Methods and Protocols. Methods in Molecular Biology. Humana Press, New York.
   Google Scholar
• Bazzo GC, Lemos-Senna E, Pires ATN. (2008). Poly(3-hydroxybutyrate)/chitosan/ketoprofen or piroxicam composite microparticles: Preparation and controlled drug release evaluation. Carbohydr Polym, 77(4): 839–844.
   Web of Science ®Google Scholar
• Beck RC, Pohlmann AR, Hoffmeister C, Gallas MR, Collnot E, Schaefer UF, Guterres SS, Lehr CM. (2007). Dexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers. Eur J Pharm Biopharm, 67(1): 18–30. 10.1016/j.ejpb.2007.01.007.
   PubMed Web of Science ®Google Scholar
• Berg ES, Skaug K. (2003). Liposome encapsulation of the internal control for whole process quality assurance of nucleic acid amplification-based assays. J Microbiol Methods, 55(1): 303–309.
   PubMed Web of Science ®Google Scholar
• Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM. (2009). Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis, 8: 6. 10.1186/1476-511X-8-6.
   PubMed Web of Science ®Google Scholar
• Bhumkar DR, Pokharkar VB. (2006). Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note. AAPS PharmSciTech, 7(2): E138–E143.
   Google Scholar
• Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. (2007). Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev, 59: 454–477. 10.1016/j.addr.2007.04.011.
   PubMed Web of Science ®Google Scholar
• Brioschi A, Zara GP, Calderoni S, Gasco MR, Mauro A. (2008). Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug. Molecules, 13: 230–254.
   PubMed Web of Science ®Google Scholar
• Brioschi A, Zenga F, Zara GP, Gasco MR, Ducati A, Mauro A. (2007). Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors? Neurol Res, 29: 324–330. 10.1179/016164107X187017.
   PubMed Web of Science ®Google Scholar
• Bruschi ML, Cardoso ML, Lucchesi MB, Gremião MP. (2003). Gelatin microparticles containing propolis obtained by spray-drying technique: preparation and characterization. Int J Pharm, 264(1-2): 45–55.
   PubMedGoogle Scholar
• Calvo P, Vila-Jato JL, Alonso MJ. (1997). Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm, 153(1): 41–50.
   Web of Science ®Google Scholar
• Cevc G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev, 56: 675–711. 10.1016/j.addr.2003.10.028.
   PubMed Web of Science ®Google Scholar
• Cortesi R, Argnani R, Esposito E, Dalpiaz A, Scatturin A, Bortolotti F, Lufino M, Guerrini R, Cavicchioni G, Incorvaia C, Menegatti E, Manservigi R. (2006). Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity. Int J Pharm, 317: 90–100. 10.1016/j.ijpharm.2006.02.050.
   PubMed Web of Science ®Google Scholar
• Diebold Y, Jarrín M, Sáez V, Carvalho EL, Orea M, Calonge M, Seijo B, Alonso MJ. (2007). Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials, 28: 1553–1564. 10.1016/j.biomaterials.2006.11.028.
   PubMed Web of Science ®Google Scholar
• Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. (2007). Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release, 123: 148–154. 10.1016/j.jconrel.2007.08.005.
   PubMed Web of Science ®Google Scholar
• Ercelen S, Zhang X, Duportail G, Grandfils C, Desbrières J, Karaeva S, Tikhonov V, Mély Y, Babak V. (2006). Physicochemical properties of low molecular weight alkylated chitosans: a new class of potential nonviral vectors for gene delivery. Colloids Surf B Biointerfaces, 51: 140–148. 10.1016/j.colsurfb.2006.06.008.
   PubMed Web of Science ®Google Scholar
• Erdem M, Yüksel E, Tay T, Cimen Y, Türk H. (2009). Synthesis of novel methacrylate based adsorbents and their sorptive properties towards p-nitrophenol from aqueous solutions. J Colloid Interface Sci, 333(1): 40–48. 10.1016/j.jcis.2009.01.014.
   PubMed Web of Science ®Google Scholar
• Esposito E, Fantin M, Marti M, Drechsler M, Paccamiccio L, Mariani P, Sivieri E, Lain F, Menegatti E, Morari M, Cortesi R. (2008). Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res, 25: 1521–1530. 10.1007/s11095-007-9514-y.
   PubMed Web of Science ®Google Scholar
• Fang JY. (2006). Nano- or submicron-sized liposomes as carriers for drug delivery. Chang Gung Med J, 29: 358–362.
   PubMedGoogle Scholar
• Fetterly GJ, Straubinger RM. (2003). Pharmacokinetics of paclitaxel-containing liposomes in rats. AAPS PharmSci, 5: 90–100. 10.1208/ps050432.
   Google Scholar
• Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. (2005). Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm, 298: 274–292. 10.1016/j.ijpharm.2005.03.031.
   PubMed Web of Science ®Google Scholar
• Garg A, Tisdale AW, Haidari E, Kokkoli E. (2009). Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide. Int J Pharm, 366: 201–210. 10.1016/j.ijpharm.2008.09.016.
   PubMed Web of Science ®Google Scholar
• Gaudana R, Jwala J, Boddu SH, Mitra AK. (2009). Recent perspectives in ocular drug delivery. Pharm Res, 26: 1197–1216. 10.1007/s11095-008-9694-0.
   PubMed Web of Science ®Google Scholar
• Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P. (2004). PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur J Pharm Biopharm, 57: 207–212. 10.1016/j.ejpb.2003.10.018.
   PubMed Web of Science ®Google Scholar
• Grant SA. (2002). The Holy Grail: long-acting local anaesthetics and liposomes. Best Pract Res Clin Anaesthesiol, 16(2): 345–352.
   PubMedGoogle Scholar
• Gregoriadis G, Da Silva H, Florence AT. (1990). A procedure for the efficient entrapment of drugs in dehydration-rehydration liposomes. Int J Pharm, 65(3): 235–242.
   Google Scholar
• Gu FX, Karnik R, Wang AZ, et al. (2007). Targeted nanoparticles for cancer therapy. Nano Today, 2(3): 14–21.
   Web of Science ®Google Scholar
• Harivardhan Reddy L, Ramachandra Murthy R. (2004). Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles. Acta Pharm, 54(2): 103–118.
   PubMedGoogle Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech, 8: Article 1. 10.1208/pt0801001.
   PubMed Web of Science ®Google Scholar
• Hatziantoniou S, Nezis IP, Margaritis LH, Demetzos C. (2007). Visualisation of liposomes prepared from skin and stratum corneum lipids by transmission electron microscopy. Micron, 38: 777–781. 10.1016/j.micron.2007.06.005.
   PubMed Web of Science ®Google Scholar
• Hoet PH, Brüske-Hohlfeld I, Salata OV. (2004). Nanoparticles - known and unknown health risks. J Nanobiotechnol, 2: 12–17.
   PubMedGoogle Scholar
• Honeywell-Nguyen PL, Bouwstra JA. (2005). Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today: Tech, 2(1): 67–74.
   PubMedGoogle Scholar
• Krauze MT, Mcknight TR, Yamashita Y, Bringas J, Noble CO, Saito R, Geletneky K, Forsayeth J, Berger MS, Jackson P, Park JW, Bankiewicz KS. (2005). Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res Brain Res Protoc, 16: 20–26. 10.1016/j.brainresprot.2005.08.003.
   PubMedGoogle Scholar
• Kreuter J. (2005). Application of nanoparticles for the delivery of drugs to the brain. Int. Congr Ser, 1277: 85–94.
   Google Scholar
• Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov AA. (1995). Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res, 674: 171–174.
   PubMed Web of Science ®Google Scholar
• Kulkarni P, Roney C, Arora V, Bennett M, Russell D, Fuchs P, White C. (2007). Imaging plaques in animal models of AD using nanoparticles encapsulated with radioiodinated clioquinol. J Nucl Med, 48(Suppl 2): 130.
   Google Scholar
• Lamprecht A, Schäfer U, Lehr CM. (2000). Structural analysis of microparticles by confocal laser scanning microscopy. AAPS PharmSciTech, 1(3): article 17.
   PubMedGoogle Scholar
• Landfester K. (2001). The generation of nanoparticles in miniemulsions. Adv Mater, 13: 765–768.
   Web of Science ®Google Scholar
• Lasic DD. (1997). Liposomes in Gene Delivery (p. 295 ). CRC Press: Boca Raton.
   Google Scholar
• Lee PW, Peng SF, Su CJ, Mi FL, Chen HL, Wei MC, Lin HJ, Sung HW. (2008). The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials, 29: 742–751. 10.1016/j.biomaterials.2007.10.034.
   PubMed Web of Science ®Google Scholar
• Liang HF, Yang TF, Huang CT, Chen MC, Sung HW. (2005). Preparation of nanoparticles composed of poly(gamma-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells. J Control Release, 105: 213–225.
   PubMed Web of Science ®Google Scholar
• Lieberman AN, Goldstein M. (1985). Bromocriptine in Parkinson disease. Pharmacol Rev, 37: 217–227.
   PubMed Web of Science ®Google Scholar
• Liu G, Garrett MR, Men P, Zhu X, Perry G, Smith MA. (2005). Nanoparticle and other metal chelation therapeutics in Alzheimer disease. Biochim Biophys Acta, 1741(3): 246–252. 10.1016/j.bbadis.2005.06.006.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P. (2006). Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm, 312: 53–60. 10.1016/j.ijpharm.2005.12.047.
   PubMed Web of Science ®Google Scholar
• Mao SR, Wang YZ, Ji HY, Bi DZ. (2003). Preparation of solid lipid nanoparticles by microemulsion technique. Acta Pharm Sinica, 38(8): 624–626.
   Google Scholar
• Miguel V, Balbi D, Castillo C, Villegas R. (1992). Reconstitution of sodium channels in large liposomes formed by the addition of acidic phospholipids and freeze-thaw sonication. J Membr Biol, 129: 37–47.
   PubMed Web of Science ®Google Scholar
• Mozafari MR. Nanocarrier Technologies: Frontiers of Nanotherapy. SpringerMüller RH, Mäder K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm, 50: 161–177.
   PubMed Web of Science ®Google Scholar
• Müller K, Klapper M, Müllen K. (2007). Polyester nanoparticles by non-aqueous emulsion polycondensation. J Polym Sci Part A: Polymer Chem, 45(6): 1101–1108.
   Web of Science ®Google Scholar
• Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK. (2009). Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release, 136: 2–13. 10.1016/j.jconrel.2008.12.018.
   PubMed Web of Science ®Google Scholar
• Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M. (2008). Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym, 73(1): 44–54.
   Web of Science ®Google Scholar
• Pardridge WM. (1999). Blood-brain barrier biology and methodology. J Neurovirol, 5: 556–569.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2002). Drug and gene delivery to the brain: the vascular route. Neuron, 36: 555–558.
   PubMed Web of Science ®Google Scholar
• Priano L, Esposti D, Esposti R, Castagna G, De Medici C, Fraschini F, Gasco MR, Mauro A. (2007). Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J Nanosci Nanotechnol, 7: 3596–3601.
   PubMed Web of Science ®Google Scholar
• Rathod S, Deshpande SG. (2008). Albumin microspheres as an ocular delivery system for pilocarpine nitrate. Indian J Pharm Sci, 70(2): 193–197.
   PubMed Web of Science ®Google Scholar
• Reimold I, Domke D, Bender J, Seyfried CA, Radunz HE, Fricker G. (2008). Delivery of nanoparticles to the brain detected by fluorescence microscopy. Eur J Pharm Biopharm, 70: 627–632. 10.1016/j.ejpb.2008.05.007.
   PubMed Web of Science ®Google Scholar
• Sakai T, Kohno H, Ishihara T, Higaki M, Saito S, Matsushima M, Mizushima Y, Kitahara K. (2006). Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Exp Eye Res, 82: 657–663. 10.1016/j.exer.2005.09.003.
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M, Mehnert W, Korting HC. (2007). Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev, 59: 427–443. 10.1016/j.addr.2007.04.006.
   PubMed Web of Science ®Google Scholar
• Schnyder A, Huwyler J. (2005). Drug transport to brain with targeted liposomes. J Amer Soc Exp NeuroTherap, 2(1): 99–107.
   PubMedGoogle Scholar
• Shenoy DB, Amiji MM. (2005). Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm, 293: 261–270.
   PubMed Web of Science ®Google Scholar
• Shim J, Seok Kang H, Park WS, Han SH, Kim J, Chang IS. (2004). Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J Control Release, 97: 477–484.
   PubMed Web of Science ®Google Scholar
• Silva GA. (2008). Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neurosci, 9(Suppl 3): S4. 10.1186/1471-2202-9-S3-S4.
   PubMed Web of Science ®Google Scholar
• Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM. (2005). Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release, 103: 123–136. 10.1016/j.jconrel.2004.11.020.
   PubMed Web of Science ®Google Scholar
• Soni V, Kohli DV, Jain SK. (2005). Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil. J Drug Target, 13: 245–250. 10.1080/10611860500107401.
   PubMed Web of Science ®Google Scholar
• Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS, Severin SE, Uhl R, Kock M, Geiger KD, Gelperina SE. (2004). Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer, 109: 759–767. 10.1002/ijc.20048.
   PubMed Web of Science ®Google Scholar
• Verma AML, Misra U, Mishra N, Bhardwaj P. (2009). Liposomes as carrier systems. InPharm Communique 2(2): 20–24.
   Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. (2003). Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm, 55: 271–277.
   PubMed Web of Science ®Google Scholar
• Visser CC, Stevanovic S, Voorwinden LH, van Bloois L, Gaillard PJ, Danhof M, Crommelin DJ, de Boer AG. (2005). Targeting liposomes with protein drugs to the blood-brain barrier in vitro. Eur J Pharm Sci, 25: 299–305. 10.1016/j.ejps.2005.03.008.
   PubMed Web of Science ®Google Scholar
• Walters KA. (2002). Dermatological and Transdermal Formulations (Drugs and the Pharmaceutical Sciences), Vol. 119. Informa Health Care.
   Google Scholar
• Xiang QY, Wang MT, Chen F, Gong T, Jian YL, Zhang ZR, Huang Y. (2007). Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles. Arch Pharm Res, 30: 519–525.
   PubMed Web of Science ®Google Scholar
• Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y. (2004). Drug delivery systems for vitreoretinal diseases. Prog Retin Eye Res, 23: 253–281. 10.1016/j.preteyeres.2004.02.003.
   PubMed Web of Science ®Google Scholar
• Young TJ, Johnson KP, Pace GW, Mishra AK. (2004). Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution. AAPS PharmSciTech, 5(1): E11. 10.1208/pt050111.
   PubMedGoogle Scholar
• Yuan H, Miao J, Du YZ, You J, Hu FQ, Zeng S. (2008). Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm, 348: 137–145. 10.1016/j.ijpharm.2007.07.012.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping QN, Huang GH, Xu WF. (2005). Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm, 294: 247–259. 10.1016/j.ijpharm.2005.01.018.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Y, Boado RJ, Pardridge WM. (2008). Lysosomal enzyme replacement of the brain with intravenous non-viral gene transfer. Pharm Res, 25: 400–406. 10.1007/s11095-007-9357-6.
   PubMed Web of Science ®Google Scholar
• Zhu J, Xue J, Guo Z, Marchant RE. (2007). Vesicle size and stability of biomimetic liposomes from 3′-sulfo-Lewis a (SuLea) containing glycolipids. Colloids Surf B Biointerfaces, 58: 242–249. 10.1016/j.colsurfb.2007.03.016.
   PubMed Web of Science ®Google Scholar